Corvus Pharmaceuticals Inc buy Barclays PLC
Start price
20.01.26
/
50%
€18.30
Target price
20.01.27
-
Performance (%)
0.00%
Price
19.01.26
€6.99
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 20.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | 0.00% |
| iShares Core DAX® | -3.141% |
| iShares Nasdaq 100 | -3.518% |
| iShares Nikkei 225® | -3.396% |
| iShares S&P 500 | -2.943% |
Comments by Barclays_PLC for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CRVS provided by MarketBeat